Starling Oncology, Inc. Proceeds from Warrant Exercises
Starling Oncology, Inc. (STLN) reported Proceeds from Warrant Exercises of $517.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-03-12
- Starling Oncology, Inc. proceeds from warrant exercises for the quarter ending 2025-12-31 was $132.00K.
- Starling Oncology, Inc. proceeds from warrant exercises for the quarter ending 2024-12-31 was $0.00.
- Starling Oncology, Inc. proceeds from warrant exercises for fiscal 2025 was $517.00K.
- Starling Oncology, Inc. proceeds from warrant exercises for fiscal 2024 was $0.00.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|
| 2025-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $517.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $385.00K 10-Q · filed 2025-11-13 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 |